News & Articles
25
Selected Filters:
Industry News
Cobra Biologics selected to manufacture plasmids for Phase I clinical trial of Scancell’s COVID-19 vaccine in 2021
The collaboration will ensure GMP production of material for the Phase 1 clinical trial of Scancell’s DNA vaccine against SARS-CoV-2
Industry News
CombiGene and Cobra Biologics sign agreement to secure GMP production of plasmids
The agreement is part of preparations for GMP production of material for the first clinical study of CG01
Product News
Cobra Biologics completes production of master cell banks for CombiGene’s epilepsy gene therapy drug candidate
Foundation for future commercial supply of CG01 secured with delivery of three master cell banks
Industry News
Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
The production agreement is part of AstraZeneca’s recently announced in-licensed programme with the University of Oxford
Industry News
Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine
OPENCORONA consortium awarded €3 million funding by Horizon 2020 to support emergency research and development against the COVID-19 outbreak
Industry News
Cobra Biologics and Centre for Process Innovation Announce Collaboration to Advance Development of Regenerative Medicines
Cobra and the CPI collaborate to develop an industrial manufacturing platform for adeno-associated virus production
Industry News
Cobra Biologics and The University of Manchester Announce Collaboration to Improve Industrial Scale-up of Mammalian Cell Bioprocessing
Agreement brings together academic and industrial expertise for the scaled manufacture of therapeutic proteins
